Holen Sie sich die Stockscreener-App
6.905
0.63%
-0.035
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
91.18%
0.677
|
7.679 | - | - | - |
| Operating Expenses |
16.23%
77.52
|
92.55 | 84.98 | 96.37 | 100.76 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
16.23%
77.52
|
92.55 | 84.98 | 96.37 | 100.76 |
| Operating Income/Loss |
9.45%
-76.85
|
-84.87 | -84.98 | -96.37 | -100.76 |
| Income/Loss From Continuing Operations Before Tax |
100.88%
0.677
|
-77.06 | - | -88.11 | -92.21 |
| Income/Loss From Continuing Operations After Tax |
8.68%
-70.38
|
-77.06 | -76.00 | -88.11 | -92.21 |
Net Income/Loss
|
8.68%
-70.38
|
-77.06 | -76.00 | -88.11 | -92.21 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.20%
171.26
|
169.23 | 8.2161 | 140.23 | 132.82 |
| Basic Earnings Per Share |
10.87%
-0.41
|
-0.46 | -0.42 | -0.63 | -0.69 |
| Diluted Earnings Per Share |
10.87%
-0.41
|
-0.46 | -0.42 | -0.63 | -0.69 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.85%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):